United States Interventional Neuroradiology Market Outlook to 2025
All the vital news, analysis, and commentary curated by our industry experts.
“What is covered in the report about the “United States Interventional Neuroradiology Market”?
GlobalData’s “United States Interventional Neuroradiology Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Interventional Neuroradiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.
The United States Interventional Neuroradiology Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Interventional Neuroradiology market.
• Global corporate-level profiles of key companies operating within the United States Interventional Neuroradiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
United States Interventional Neuroradiology is segmented as follows:
• Neurovascular Accessory Devices
• Neurovascular Coiling Assist Devices
• Neurovascular Embolization Devices
• Neurovascular Thrombectomy Devices
• Intracranial Stents
Key Reasons to Purchase
The United States Interventional Neuroradiology Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Key companies covered in the “United States Interventional Neuroradiology Market Outlook to 2025” report
• Medtronic plc
• Stryker Corp
• Penumbra Inc
• MicroVention Inc
The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 26,400+ pipeline product profiles
• 52,400+ marketed product profiles
• 44,600+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 42,000+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Interventional Neuroradiology Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Interventional Neuroradiology Market, United States 9
3.1 Interventional Neuroradiology Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Neurovascular Accessory Devices Market, United States, Revenue ($m), by Segment, 2015-2025 12
3.1.2 Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), by Segment, 2015-2025 14
3.1.3 Neurovascular Embolization Devices Market, United States, Revenue ($m), by Segment, 2015-2025 16
3.1.4 Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2015-2025 19
3.2 Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 21
3.2.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2015-2025 24
3.2.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025 26
3.2.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2015-2025 28
3.2.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025 31
3.3 Interventional Neuroradiology Market, United States, Average Price ($), 2015-2025 33
3.4 Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), 2018 35
3.5 Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2018 36
4 Overview of Key Companies in United States, Interventional Neuroradiology Market 38
4.1 Medtronic Plc 38
4.1.1 Company Overview 38
4.2 Stryker Corp 38
4.2.1 Company Overview 38
4.3 Penumbra Inc 38
4.3.1 Company Overview 38
4.4 MicroVention Inc 39
4.4.1 Company Overview 39
4.5 MIZUHO Co Ltd 39
4.5.1 Company Overview 39
4.6 CERENOVUS 39
4.6.1 Company Overview 39
5 Interventional Neuroradiology Market Pipeline Products 40
6 Financial Deals Landscape 41
6.1 Debt Offerings 41
6.1.1 Stryker Prices Public Offering of 1% Notes Due 2031 for USD826.2 Million 41
6.1.2 Stryker Prices Public Offering of
0.75% Notes Due 2029 for USD881.3 Million 43
6.1.3 Stryker Prices Public Offering of
0.25% Notes Due 2024 for USD936.4 Million 45
6.2 Equity Offerings 47
6.2.1 Silk Road Medical Raises USD190.7 Million in Public Offering of Shares 47
6.2.2 Silk Road Medical Raises USD120 Million in IPO of Shares 49
6.2.3 Stryker Plans to Raise Funds through Public Offering of Securities 51
6.3 Merger 52
6.3.1 Pulse Therapeutics and ICHOR Vascular Merge 52
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Oct 08, 2019: CardioWise named a top-ten finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub 53
7.1.2 Sep 30, 2019: Johnson & Johnson appoints Carlton Lawson to area Managing Director, Consumer, Northern Europe 53
7.1.3 Aug 29, 2019: Sri Kosaraju promoted to President and CFO of Penumbra 53
7.1.4 Aug 12, 2019: Stryker announces commercial structure realignment 54
7.1.5 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 54
7.1.6 Jul 10, 2019: Synchronized cardiovascular support now ready for the market 54
7.1.7 Jul 03, 2019: Britta Lesaux appointed president & CEO Philips Canada 55
7.1.8 May 02, 2019: Axogen names new members to Board of Directors 55
7.1.9 Mar 27, 2019: Stryker announces new Vice President, chief legal officer 56
7.1.10 Jan 22, 2019: AxoGen names Eric Sandberg as Chief Commercial Officer 57
7.1.11 Jan 18, 2019: Penumbra names Janet Leeds and Surbhi Sarna to its board of directors 57
7.1.12 Jan 07, 2019: AxoGen names Christopher Crisman as Vice President,U.S. Sales 58
7.2 Financial Announcements 59
7.2.1 Nov 07, 2019: Penumbra reports third quarter 2019 financial results 59
7.2.2 Nov 06, 2019: Axogen reports 2019 third quarter financial results 59
7.2.3 Oct 29, 2019: Stryker reports third quarter 2019 operating results 60
7.2.4 Oct 29, 2019: Silk Road Medical reports third quarter 2019 financial results 61
7.2.5 Oct 15, 2019: Johnson & Johnson reports 2019 Third-Quarter Results 62
7.2.6 Aug 06, 2019: Axogen reports 2019 second quarter financial results 62
7.2.7 Aug 06, 2019: Penumbra reports second quarter 2019 financial results 63
7.2.8 Jul 29, 2019: Silk Road Medical reports second quarter 2019 financial results and raises 2019 outlook 63
7.2.9 Jul 25, 2019: Stryker reports second quarter 2019 operating results 64
7.2.10 Jul 16, 2019: Johnson & Johnson reports 2019 Second-Quarter Results 65
7.2.11 Jul 12, 2019: New test could reduce premature births by up to 30 per cent 66
7.2.12 May 08, 2019: Silk Road Medical reports first quarter 2019 financial results 68
7.2.13 May 08, 2019: Axogen reports 2019 first quarter financial results 69
7.2.14 May 07, 2019: Penumbra announces first quarter 2019 financial results 69
7.2.15 Apr 23, 2019: Stryker announces first quarter 2019 operating results 70
7.2.16 Apr 16, 2019: Johnson & Johnson reports 2019 first-quarter results 70
7.2.17 Mar 29, 2019: Eisai announces presentations of Lenvatinib at the 110th American Association for Cancer Research (AACR) Annual Meeting 71
7.2.18 Feb 26, 2019: Axogen announces 2018 fourth quarter and full year 2018 financial results 74
7.2.19 Feb 26, 2019: Penumbra announces fourth quarter and full year 2018 financial results 75
7.2.20 Jan 29, 2019: Stryker reports 2018 results and 2019 outlook 76
7.2.21 Jan 22, 2019: Johnson & Johnson reports 2018 fourth-quarter results 77
7.2.22 Jan 07, 2019: AxoGen pre-announces financial and operational results 79
7.3 Government and Public Interest 81
7.3.1 Feb 08, 2019: Johnson & Johnson to disclose drug prices in television ads 81
7.3.2 Jan 09, 2019: Medtronic Foundation Recognizes 12 Bakken Invitation Honorees for Driving Positive Change in Healthcare 81
7.4 Legal And Regulatory 82
7.4.1 Sep 26, 2019: TSO3 announces receipt of final Court approval for plan of arrangement with Stryker 82
7.4.2 Feb 15, 2019: BRAVO BIDCO: Update on the proposed acquisition of BTG 82
7.5 Other Significant Developments 83
7.5.1 Jun 14, 2019: Stryker to invest €200m in RD&I projects in Ireland 83
7.5.2 May 15, 2019: Johnson & Johnson outlines strategy to deliver above-market growth at 2019 pharmaceutical business review 83
7.6 Product News 84
7.6.1 Jul 23, 2019: ZOLL rebrands Payor Logic Solutions as ZOLL AR Boost 84
7.6.2 Feb 19, 2019: ZOLL showcases systems of care products at EMS Today 2019 84
7.7 Strategy And Business Planning 85
7.7.1 Nov 05, 2019: Stryker signs agreement to acquire Wright Medical for $5.4bn 85
8 Appendix 87
8.1 Research Methodology 88
8.1.1 Coverage 88
8.1.2 Secondary Research 88
8.1.3 Primary Research 89
8.1.4 Market Modeling and Forecasting 90
8.1.5 Company Share Analysis 91
8.1.6 Distribution Share Analysis 92
8.1.7 Benchmarking 92
8.2 GlobalData Consulting 93
8.3 Contact Us 93
8.4 Disclaimer 93
Frequently asked questions
Undecided about purchasing this report?Enquire Before Buying
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Business Intelligence & Marketing Manager, SAL Heavy Lift
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
Market Analyst & Management, Liebherr-Werk
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Head of Key Accounts, Saab AB
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Marketing Intelligence Manager, Portugal Foods
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Head of Customer Insight and Research, Standard Chartered
Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.
I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.
I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.
Head of Consumer Sensory Insights, Givaudan
“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.
Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”
Senior Account Manager, TSYS
GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.
I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.
One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.